NM_052813.5:c.297G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_052813.5(CARD9):​c.297G>A​(p.Pro99Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0199 in 1,602,174 control chromosomes in the GnomAD database, including 838 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 82 hom., cov: 34)
Exomes 𝑓: 0.020 ( 756 hom. )

Consequence

CARD9
NM_052813.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.818

Publications

7 publications found
Variant links:
Genes affected
CARD9 (HGNC:16391): (caspase recruitment domain family member 9) The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008]
CARD9 Gene-Disease associations (from GenCC):
  • deep dermatophytosis
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • predisposition to invasive fungal disease due to CARD9 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 9-136371349-C-T is Benign according to our data. Variant chr9-136371349-C-T is described in ClinVar as Benign. ClinVar VariationId is 365853.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.818 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0837 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD9NM_052813.5 linkc.297G>A p.Pro99Pro synonymous_variant Exon 3 of 13 ENST00000371732.10 NP_434700.2 Q9H257-1A0A024R8F1
CARD9NM_052814.4 linkc.297G>A p.Pro99Pro synonymous_variant Exon 3 of 13 NP_434701.1 Q9H257-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD9ENST00000371732.10 linkc.297G>A p.Pro99Pro synonymous_variant Exon 3 of 13 1 NM_052813.5 ENSP00000360797.5 Q9H257-1
ENSG00000289701ENST00000696169.1 linkn.297G>A non_coding_transcript_exon_variant Exon 3 of 13 ENSP00000512460.1

Frequencies

GnomAD3 genomes
AF:
0.0192
AC:
2921
AN:
152212
Hom.:
78
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00557
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.0869
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.0130
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0169
Gnomad OTH
AF:
0.0186
GnomAD2 exomes
AF:
0.0326
AC:
7451
AN:
228396
AF XY:
0.0269
show subpopulations
Gnomad AFR exome
AF:
0.00533
Gnomad AMR exome
AF:
0.153
Gnomad ASJ exome
AF:
0.00377
Gnomad EAS exome
AF:
0.000117
Gnomad FIN exome
AF:
0.0171
Gnomad NFE exome
AF:
0.0175
Gnomad OTH exome
AF:
0.0250
GnomAD4 exome
AF:
0.0200
AC:
29002
AN:
1449844
Hom.:
756
Cov.:
34
AF XY:
0.0190
AC XY:
13712
AN XY:
720220
show subpopulations
African (AFR)
AF:
0.00420
AC:
140
AN:
33346
American (AMR)
AF:
0.148
AC:
6404
AN:
43152
Ashkenazi Jewish (ASJ)
AF:
0.00398
AC:
103
AN:
25848
East Asian (EAS)
AF:
0.000688
AC:
27
AN:
39240
South Asian (SAS)
AF:
0.00391
AC:
331
AN:
84548
European-Finnish (FIN)
AF:
0.0178
AC:
909
AN:
51058
Middle Eastern (MID)
AF:
0.00452
AC:
26
AN:
5756
European-Non Finnish (NFE)
AF:
0.0180
AC:
19980
AN:
1106976
Other (OTH)
AF:
0.0181
AC:
1082
AN:
59920
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
1938
3876
5813
7751
9689
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
836
1672
2508
3344
4180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0193
AC:
2933
AN:
152330
Hom.:
82
Cov.:
34
AF XY:
0.0193
AC XY:
1436
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.00556
AC:
231
AN:
41574
American (AMR)
AF:
0.0876
AC:
1340
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00403
AC:
14
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5188
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4830
European-Finnish (FIN)
AF:
0.0130
AC:
138
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0169
AC:
1147
AN:
68022
Other (OTH)
AF:
0.0184
AC:
39
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
158
316
475
633
791
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0167
Hom.:
15
Bravo
AF:
0.0254
Asia WGS
AF:
0.00751
AC:
26
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Predisposition to invasive fungal disease due to CARD9 deficiency Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 08, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 25% of patients studied by a panel of primary immunodeficiencies. Number of patients: 22. Only high quality variants are reported. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.69
DANN
Benign
0.90
PhyloP100
-0.82
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115131813; hg19: chr9-139265801; COSMIC: COSV53739282; COSMIC: COSV53739282; API